弥漫性大B细胞淋巴瘤-话题@MedSci

#弥漫性大B细胞淋巴瘤#

54篇内容 | 4073人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1290159, encodeId=bdc0129015947, content=<a href='/topic/show?id=c5795004ece' target=_blank style='color:#2F92EE;'>#弥漫性大B细胞淋巴瘤#</a>, objectTitle=Lancet oncol：Polatuzumab vedotin联合免疫化疗用于弥漫性大B细胞淋巴瘤的安全性和疗效, objectType=article, longId=166508, objectId=9b0116650850, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9b0116650850, replyNumber=0, likeNumber=69, createdTime=2019-05-22, rootId=0, userName=bnjfy, userId=346311, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b0116650850, moduleTitle=Lancet oncol：Polatuzumab vedotin联合免疫化疗用于弥漫性大B细胞淋巴瘤的安全性和疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9b0116650850)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1290158, encodeId=6b521290158b8, content=<a href='/topic/show?id=c5795004ece' target=_blank style='color:#2F92EE;'>#弥漫性大B细胞淋巴瘤#</a>, objectTitle=Clin Cancer Res:弥漫性大B细胞淋巴瘤（DLBCL）治疗耐药新机制, objectType=article, longId=164689, objectId=774b16468924, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=774b16468924, replyNumber=0, likeNumber=85, createdTime=2019-04-22, rootId=0, userName=bnjfy, userId=346311, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=774b16468924, moduleTitle=Clin Cancer Res:弥漫性大B细胞淋巴瘤（DLBCL）治疗耐药新机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=774b16468924)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1290157, encodeId=5bee129015efd, content=<a href='/topic/show?id=c5795004ece' target=_blank style='color:#2F92EE;'>#弥漫性大B细胞淋巴瘤#</a>, objectTitle=Blood：PD-1/PD-L1和p53缺失协同促进弥漫性大B细胞淋巴瘤进展, objectType=article, longId=164252, objectId=ced71642525f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ced71642525f, replyNumber=0, likeNumber=63, createdTime=2019-04-15, rootId=0, userName=bnjfy, userId=346311, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ced71642525f, moduleTitle=Blood：PD-1/PD-L1和p53缺失协同促进弥漫性大B细胞淋巴瘤进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ced71642525f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1290156, encodeId=719a1290156f4, content=<a href='/topic/show?id=c5795004ece' target=_blank style='color:#2F92EE;'>#弥漫性大B细胞淋巴瘤#</a>, objectTitle=原发性子宫及双侧附件弥漫性大B细胞淋巴瘤1例, objectType=article, longId=163896, objectId=6146163896f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6146163896f8, replyNumber=0, likeNumber=73, createdTime=2019-04-10, rootId=0, userName=bnjfy, userId=346311, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6146163896f8, moduleTitle=原发性子宫及双侧附件弥漫性大B细胞淋巴瘤1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6146163896f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1290155, encodeId=25ba12901556c, content=<a href='/topic/show?id=c5795004ece' target=_blank style='color:#2F92EE;'>#弥漫性大B细胞淋巴瘤#</a>, objectTitle=Blood：Venetoclax联合R-CHOP可安全有效治疗弥漫性大B细胞淋巴瘤, objectType=article, longId=162820, objectId=0e731628209a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e731628209a, replyNumber=0, likeNumber=82, createdTime=2019-03-25, rootId=0, userName=bnjfy, userId=346311, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e731628209a, moduleTitle=Blood：Venetoclax联合R-CHOP可安全有效治疗弥漫性大B细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0e731628209a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1290154, encodeId=702a1290154b8, content=<a href='/topic/show?id=c5795004ece' target=_blank style='color:#2F92EE;'>#弥漫性大B细胞淋巴瘤#</a>, objectTitle=NEJM：Tisagenlecleucel治疗复发或难治性弥漫性大B细胞淋巴瘤II期结果显著, objectType=article, longId=157227, objectId=faef15e22769, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=faef15e22769, replyNumber=0, likeNumber=79, createdTime=2019-01-05, rootId=0, userName=bnjfy, userId=346311, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=faef15e22769, moduleTitle=NEJM：Tisagenlecleucel治疗复发或难治性弥漫性大B细胞淋巴瘤II期结果显著, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=faef15e22769)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1290153, encodeId=72a21290153ba, content=<a href='/topic/show?id=c5795004ece' target=_blank style='color:#2F92EE;'>#弥漫性大B细胞淋巴瘤#</a>, objectTitle=蔡清清教授：老年弥漫性大B细胞淋巴瘤治疗窘境仍待破解, objectType=article, longId=155982, objectId=6be11559825a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6be11559825a, replyNumber=0, likeNumber=55, createdTime=2018-12-19, rootId=0, userName=bnjfy, userId=346311, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6be11559825a, moduleTitle=蔡清清教授：老年弥漫性大B细胞淋巴瘤治疗窘境仍待破解, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6be11559825a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1290152, encodeId=a9951290152a3, content=<a href='/topic/show?id=c5795004ece' target=_blank style='color:#2F92EE;'>#弥漫性大B细胞淋巴瘤#</a>, objectTitle=NEJM：Tisagenlecleucel用于复发或难治性弥漫性大B细胞淋巴瘤, objectType=article, longId=155103, objectId=ddf415510378, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ddf415510378, replyNumber=0, likeNumber=80, createdTime=2018-12-06, rootId=0, userName=bnjfy, userId=346311, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ddf415510378, moduleTitle=NEJM：Tisagenlecleucel用于复发或难治性弥漫性大B细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ddf415510378)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1290151, encodeId=71ba129015131, content=<a href='/topic/show?id=c5795004ece' target=_blank style='color:#2F92EE;'>#弥漫性大B细胞淋巴瘤#</a>, objectTitle=腰椎管狭窄症合并左骶髂关节弥漫性大B细胞淋巴瘤1例, objectType=article, longId=154662, objectId=d1d31546622a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d1d31546622a, replyNumber=0, likeNumber=71, createdTime=2018-12-01, rootId=0, userName=bnjfy, userId=346311, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d1d31546622a, moduleTitle=腰椎管狭窄症合并左骶髂关节弥漫性大B细胞淋巴瘤1例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d1d31546622a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1290150, encodeId=6260129015047, content=<a href='/topic/show?id=c5795004ece' target=_blank style='color:#2F92EE;'>#弥漫性大B细胞淋巴瘤#</a>, objectTitle=2018 BSH指南：原发性中枢神经系统弥漫性大B细胞淋巴瘤的诊断和管理, objectType=article, longId=154562, objectId=e874154562ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e874154562ec, replyNumber=0, likeNumber=0, createdTime=2018-11-30, rootId=0, userName=bnjfy, userId=346311, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e874154562ec, moduleTitle=2018 BSH指南：原发性中枢神经系统弥漫性大B细胞淋巴瘤的诊断和管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e874154562ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1290149, encodeId=c3211290149e4, content=<a href='/topic/show?id=c5795004ece' target=_blank style='color:#2F92EE;'>#弥漫性大B细胞淋巴瘤#</a>, objectTitle=Blood：在弥漫性大B细胞淋巴瘤中，B细胞受体介导的NFATc1激活可诱导IL-10/STAT3/PD-L1信号, objectType=article, longId=148786, objectId=bee6148e86b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bee6148e86b0, replyNumber=0, likeNumber=63, createdTime=2018-09-15, rootId=0, userName=bnjfy, userId=346311, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bee6148e86b0, moduleTitle=Blood：在弥漫性大B细胞淋巴瘤中，B细胞受体介导的NFATc1激活可诱导IL-10/STAT3/PD-L1信号, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bee6148e86b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1290148, encodeId=1820129014888, content=<a href='/topic/show?id=c5795004ece' target=_blank style='color:#2F92EE;'>#弥漫性大B细胞淋巴瘤#</a>, objectTitle=Neurology：弥漫性大B细胞淋巴瘤表现为双侧相继受累的动眼神经病变, objectType=article, longId=145217, objectId=49aa14521efb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=49aa14521efb, replyNumber=0, likeNumber=0, createdTime=2018-07-27, rootId=0, userName=bnjfy, userId=346311, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=49aa14521efb, moduleTitle=Neurology：弥漫性大B细胞淋巴瘤表现为双侧相继受累的动眼神经病变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=49aa14521efb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1290147, encodeId=bff7129014e8e, content=<a href='/topic/show?id=c5795004ece' target=_blank style='color:#2F92EE;'>#弥漫性大B细胞淋巴瘤#</a>, objectTitle=Lancet Haematol：R-GemOx一线治疗弥漫性大B细胞淋巴瘤老年患者怎么样？, objectType=article, longId=144538, objectId=cc1d14453882, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cc1d14453882, replyNumber=0, likeNumber=96, createdTime=2018-07-18, rootId=0, userName=bnjfy, userId=346311, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cc1d14453882, moduleTitle=Lancet Haematol：R-GemOx一线治疗弥漫性大B细胞淋巴瘤老年患者怎么样？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cc1d14453882)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1290146, encodeId=000c12901463d, content=<a href='/topic/show?id=c5795004ece' target=_blank style='color:#2F92EE;'>#弥漫性大B细胞淋巴瘤#</a>, objectTitle=NEJM：里程碑式研究：弥漫性大B细胞淋巴瘤分类迈出更精准一步, objectType=article, longId=135549, objectId=cdbc1355495e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cdbc1355495e, replyNumber=0, likeNumber=78, createdTime=2018-04-18, rootId=0, userName=bnjfy, userId=346311, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cdbc1355495e, moduleTitle=NEJM：里程碑式研究：弥漫性大B细胞淋巴瘤分类迈出更精准一步, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cdbc1355495e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1290145, encodeId=da07129014577, content=<a href='/topic/show?id=c5795004ece' target=_blank style='color:#2F92EE;'>#弥漫性大B细胞淋巴瘤#</a>, objectTitle=Blood：弥漫性大B细胞淋巴瘤通过激活存活信号通路或获得影响药物与靶点结合的EZH2突变，从而对EZH2抑制剂耐药, objectType=article, longId=133365, objectId=e4531333650d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e4531333650d, replyNumber=0, likeNumber=81, createdTime=2018-03-26, rootId=0, userName=bnjfy, userId=346311, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e4531333650d, moduleTitle=Blood：弥漫性大B细胞淋巴瘤通过激活存活信号通路或获得影响药物与靶点结合的EZH2突变，从而对EZH2抑制剂耐药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e4531333650d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1290144, encodeId=eaa9129014415, content=<a href='/topic/show?id=c5795004ece' target=_blank style='color:#2F92EE;'>#弥漫性大B细胞淋巴瘤#</a>, objectTitle=2018 ILROG指南：复发/难治性弥漫性大B细胞淋巴瘤患者放射治疗的作用, objectType=article, longId=129689, objectId=eb3012968908, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb3012968908, replyNumber=0, likeNumber=47, createdTime=2018-02-13, rootId=0, userName=bnjfy, userId=346311, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb3012968908, moduleTitle=2018 ILROG指南：复发/难治性弥漫性大B细胞淋巴瘤患者放射治疗的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eb3012968908)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1290143, encodeId=650b129014309, content=<a href='/topic/show?id=c5795004ece' target=_blank style='color:#2F92EE;'>#弥漫性大B细胞淋巴瘤#</a>, objectTitle=Blood：依鲁替尼联合R-ICE用于复发性/难治性弥漫性大B细胞淋巴瘤患者的I期研究结果, objectType=article, longId=128600, objectId=c14a1286000a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c14a1286000a, replyNumber=0, likeNumber=70, createdTime=2018-02-04, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c14a1286000a, moduleTitle=Blood：依鲁替尼联合R-ICE用于复发性/难治性弥漫性大B细胞淋巴瘤患者的I期研究结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c14a1286000a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1290142, encodeId=a3b21290142b6, content=<a href='/topic/show?id=c5795004ece' target=_blank style='color:#2F92EE;'>#弥漫性大B细胞淋巴瘤#</a>, objectTitle=Blood：国际SCHOLAR-1研究结果：难治性弥漫性大B细胞淋巴瘤的预后情况。, objectType=article, longId=107726, objectId=94d510e7261d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=94d510e7261d, replyNumber=0, likeNumber=59, createdTime=2017-08-06, rootId=0, userName=bnjfy, userId=346311, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=94d510e7261d, moduleTitle=Blood：国际SCHOLAR-1研究结果：难治性弥漫性大B细胞淋巴瘤的预后情况。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=94d510e7261d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1290141, encodeId=0b76129014178, content=<a href='/topic/show?id=c5795004ece' target=_blank style='color:#2F92EE;'>#弥漫性大B细胞淋巴瘤#</a>, objectTitle=SCI REP：感染是弥漫性大B细胞淋巴瘤患者死亡的独立预测因子！, objectType=article, longId=104214, objectId=35571042148f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=35571042148f, replyNumber=0, likeNumber=64, createdTime=2017-07-02, rootId=0, userName=bnjfy, userId=346311, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=35571042148f, moduleTitle=SCI REP：感染是弥漫性大B细胞淋巴瘤患者死亡的独立预测因子！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=35571042148f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1290140, encodeId=76591290140e1, content=<a href='/topic/show?id=c5795004ece' target=_blank style='color:#2F92EE;'>#弥漫性大B细胞淋巴瘤#</a>, objectTitle=Lancet Oncol：弥漫性大B细胞淋巴瘤的高风险年轻患者的治疗研究, objectType=article, longId=103953, objectId=9e52103953a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9e52103953a4, replyNumber=0, likeNumber=76, createdTime=2017-07-01, rootId=0, userName=bnjfy, userId=346311, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9e52103953a4, moduleTitle=Lancet Oncol：弥漫性大B细胞淋巴瘤的高风险年轻患者的治疗研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9e52103953a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

弥漫性大B细胞淋巴瘤

2020-05-29

bnjfy (审核中...)

前往app查看评论内容

#弥漫性大B细胞淋巴瘤#

Lancet oncol：Polatuzumab vedotin联合免疫化疗用于弥漫性大B细胞淋巴瘤的安全性和疗效

2019-05-22

bnjfy (审核中...)

前往app查看评论内容

#弥漫性大B细胞淋巴瘤#

Clin Cancer Res:弥漫性大B细胞淋巴瘤（DLBCL）治疗耐药新机制

2019-04-22

bnjfy (审核中...)

前往app查看评论内容

#弥漫性大B细胞淋巴瘤#

Blood：PD-1/PD-L1和p53缺失协同促进弥漫性大B细胞淋巴瘤进展

2019-04-15

bnjfy (审核中...)

前往app查看评论内容

#弥漫性大B细胞淋巴瘤#

原发性子宫及双侧附件弥漫性大B细胞淋巴瘤1例

2019-04-10

bnjfy (审核中...)

前往app查看评论内容

#弥漫性大B细胞淋巴瘤#

Blood：Venetoclax联合R-CHOP可安全有效治疗弥漫性大B细胞淋巴瘤

2019-03-25

bnjfy (审核中...)

前往app查看评论内容

#弥漫性大B细胞淋巴瘤#

NEJM：Tisagenlecleucel治疗复发或难治性弥漫性大B细胞淋巴瘤II期结果显著

2019-01-05

bnjfy (审核中...)

前往app查看评论内容

#弥漫性大B细胞淋巴瘤#

蔡清清教授：老年弥漫性大B细胞淋巴瘤治疗窘境仍待破解

2018-12-19

bnjfy (审核中...)

前往app查看评论内容

#弥漫性大B细胞淋巴瘤#

NEJM：Tisagenlecleucel用于复发或难治性弥漫性大B细胞淋巴瘤

2018-12-06

bnjfy (审核中...)

前往app查看评论内容

#弥漫性大B细胞淋巴瘤#

腰椎管狭窄症合并左骶髂关节弥漫性大B细胞淋巴瘤1例

2018-12-01

bnjfy (审核中...)

前往app查看评论内容

#弥漫性大B细胞淋巴瘤#

2018 BSH指南：原发性中枢神经系统弥漫性大B细胞淋巴瘤的诊断和管理

2018-11-30

bnjfy (审核中...)

前往app查看评论内容

#弥漫性大B细胞淋巴瘤#

Blood：在弥漫性大B细胞淋巴瘤中，B细胞受体介导的NFATc1激活可诱导IL-10/STAT3/PD-L1信号

2018-09-15

bnjfy (审核中...)

前往app查看评论内容

#弥漫性大B细胞淋巴瘤#

Neurology：弥漫性大B细胞淋巴瘤表现为双侧相继受累的动眼神经病变

2018-07-27

bnjfy (审核中...)

前往app查看评论内容

#弥漫性大B细胞淋巴瘤#

Lancet Haematol：R-GemOx一线治疗弥漫性大B细胞淋巴瘤老年患者怎么样？

2018-07-18

bnjfy (审核中...)

前往app查看评论内容

#弥漫性大B细胞淋巴瘤#

NEJM：里程碑式研究：弥漫性大B细胞淋巴瘤分类迈出更精准一步

2018-04-18

bnjfy (审核中...)

前往app查看评论内容

#弥漫性大B细胞淋巴瘤#

Blood：弥漫性大B细胞淋巴瘤通过激活存活信号通路或获得影响药物与靶点结合的EZH2突变，从而对EZH2抑制剂耐药

2018-03-26

bnjfy (审核中...)

前往app查看评论内容

#弥漫性大B细胞淋巴瘤#

2018 ILROG指南：复发/难治性弥漫性大B细胞淋巴瘤患者放射治疗的作用

2018-02-13

zhouqu_8 (审核中...)

前往app查看评论内容

#弥漫性大B细胞淋巴瘤#

Blood：依鲁替尼联合R-ICE用于复发性/难治性弥漫性大B细胞淋巴瘤患者的I期研究结果

2018-02-04

bnjfy (审核中...)

前往app查看评论内容

#弥漫性大B细胞淋巴瘤#

Blood：国际SCHOLAR-1研究结果：难治性弥漫性大B细胞淋巴瘤的预后情况。

2017-08-06

bnjfy (审核中...)

前往app查看评论内容

#弥漫性大B细胞淋巴瘤#

SCI REP：感染是弥漫性大B细胞淋巴瘤患者死亡的独立预测因子！

2017-07-02

bnjfy (审核中...)

前往app查看评论内容

#弥漫性大B细胞淋巴瘤#

Lancet Oncol：弥漫性大B细胞淋巴瘤的高风险年轻患者的治疗研究

2017-07-01

科室
- - 订阅+
  - 更多科室
工具
服务